Association between event-free survival and overall survival in early-stage triple-negative breast cancer - supplementary material

<b>Table S1</b>. Key characteristics of single-arm trials and cohort studies<b>Table S2</b>. Base case and sensitivity analyses of individual-level association<b>Table S3.</b> Predicted results for the trials with immunotherapy using the model without fixed intercept based on non-immunotherapy trials<b>Table S4.</b> Validation of individual level association<b>Table S5.</b> Search strategy for the target literature review<b>Figure S1.</b> PRISMA chart<b>Figure S2.</b> Trial-level association between EFS and OS excluding immunotherapy trials<b>Figure S3.</b> Validation of trial-level association